Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article reviews research on shikuwasa and nobiletin. It is informational only and is not medical advice. Not medical advice. Consult a qualified healthcare professional before adding any supplement to your routine, particularly if you take medications or have an ongoing health condition.

If you’ve been reading about Okinawan longevity and came across shikuwasa — the small, intensely tart citrus squeezed over grilled fish across the island’s northern villages — you’ve probably also encountered nobiletin. The compound shows up in supplement marketing framed as “the Okinawan longevity molecule,” occasionally alongside statistics from the Okinawa Centenarian Study. What those framings rarely include: the bulk of nobiletin research has been conducted in rodents and cell lines, the human dietary data links intake at food scales not supplement doses, and the biological pathway where the most interesting recent findings appear — the circadian clock — is not the longevity pathway most buyers expect.

What follows is a closer look at what the evidence involves, where the gaps are, and how shikuwasa-derived nobiletin fits into the broader supplement landscape.

TL;DR

• Shikuwasa (Citrus depressa) is a small Okinawan citrus with one of the highest documented nobiletin concentrations of any naturally occurring food source.
• Nobiletin is a polymethoxylated flavone — a structurally distinct polyphenol class — studied in rodent and in vitro models for effects on circadian rhythm regulation, lipid metabolism, and metabolic markers.
• A 2016 study published in Nature Chemical Biology (He et al.) identified nobiletin as a modulator of RORα/γ nuclear receptors, which function within the molecular circadian clock’s feedback loop — a finding that generated significant downstream research interest.
• Human clinical trial evidence for nobiletin supplementation is limited. Observational data linking citrus flavonoid intake to health outcomes exists, but does not isolate nobiletin from total citrus consumption.
• The Okinawan context for shikuwasa is dietary — the fruit consumed as juice or condiment at regional scale — not supplement-dose nobiletin isolate.

What shikuwasa is and where it grows

Citrus depressa, called shikuwasa (シークワーサー) in Okinawan dialect, is a small citrus native to Okinawa and Taiwan. The name translates roughly to “tart eating” — which captures the flavor profile accurately. The fruit is roughly the size of a kumquat, sour and aromatic, with a thin green rind that yellows at full ripeness.

Traditional Okinawan uses are straightforwardly culinary: the juice squeezed over grilled fish, stirred into awamori (the island’s distilled rice spirit), or used as a seasoning the way mainland Japan uses sudachi or yuzu. Fresh harvest runs from August through November in Okinawa’s northern region, particularly around Nago, which supplies most of the commercial crop. Unripe green fruit, harvested in late summer, carries the highest nobiletin content by measured concentration — a distinction that matters when comparing fresh juice, ripe juice, dried peel extract, and isolated supplement forms.

Shikuwasa was not historically consumed as an isolated supplement. Epidemiological observations linking it to longevity in Okinawan elderly populations sit within broader dietary patterns: high fish intake, sweet potato as a primary carbohydrate, abundant vegetables, and the hara hachi bu caloric moderation practice documented by the Okinawa Centenarian Study (Bradley Willcox et al.). One fruit in a complex dietary matrix is not a controlled variable.

Nobiletin: the compound and what the research has measured

Nobiletin is a polymethoxylated flavone — a flavonoid subclass defined by multiple methoxy substituents on the flavone backbone. This structure makes nobiletin considerably more lipid-soluble than most polyphenols (which are water-soluble), a property that affects both its absorption profile and the biological compartments it can reach after oral consumption.

The most cited recent nobiletin research is a 2016 paper by He et al. published in Nature Chemical Biology. The study identified nobiletin as a direct ligand for RORα and RORγ nuclear receptors — components of the molecular circadian clock’s positive transcriptional feedback loop. By binding ROR receptors, nobiletin was shown to enhance the transcription of clock-controlled genes including BMAL1, which regulates downstream metabolic and cellular processes tied to time-of-day signaling.

In mouse models used in that line of research, dietary nobiletin at 0.1–0.5% of total feed was associated with:

• Reduced weight gain and adiposity in high-fat diet groups
• Improved glucose tolerance in metabolically challenged animals
• Enhanced locomotor rhythm amplitude — a measure of circadian clock coherence
• Favorable changes in lipid metabolism markers

These findings attracted attention because they linked a naturally occurring citrus compound to both metabolic regulation and circadian biology — two research areas where disrupted function is associated with accelerated aging phenotypes in rodent models.

What this record supports, calibrated: in animal models at pharmacological dietary concentrations, nobiletin is associated with improved metabolic markers and circadian clock activity. The mechanistic hypothesis connecting these effects to human health is biologically coherent.

What it does not support: confirmed benefits in humans from supplement-dose nobiletin. No large-scale human RCT has evaluated nobiletin supplementation against metabolic or longevity endpoints in a controlled design.

Where the human evidence currently sits

Human data on nobiletin specifically is primarily observational and indirect. Population-level studies have examined total citrus flavonoid intake and health outcomes across large cohorts — these measure dietary citrus consumption in thousands of subjects, not isolated nobiletin supplementation. Japanese longitudinal cohort data has found associations between higher total citrus flavonoid intake and cardiovascular markers; nobiletin is one of many flavonoids in that dietary category, and any association belongs to the full citrus flavonoid pattern from food sources, not to the single compound.

No peer-reviewed human RCT has specifically evaluated nobiletin as a supplement intervention. This gap is not unusual in the polyphenol research landscape — many plant-derived compounds with substantial preclinical investigation have limited human trial records — but it is critical for anyone evaluating a supplement purchase.

The circadian biology angle specifically has not been tested in humans with nobiletin. Human circadian rhythm interventions have been studied primarily through light exposure, melatonin timing, time-restricted eating, and temperature manipulation. Whether supplement-dose nobiletin modulates human ROR receptor activity at physiologically relevant concentrations is not established.

The Okinawa centenarian context — and why it doesn’t transfer directly to supplementation

The Okinawa Centenarian Study documented a dietary pattern in the highest-centenarian-density cohort that included shikuwasa alongside sweet potato, abundant vegetables, fish, tofu, and a generally low-calorie traditional diet. Shikuwasa appears as one variable in a complex dietary matrix — not as an isolated intervention.

The centenarian cohort consumed whole fruit or fresh-squeezed juice at seasonal availability: a dietary exposure delivering nobiletin in a food matrix with fiber, other flavonoids, and micronutrients, at volumes reflecting regional food culture rather than therapeutic doses. This is a different exposure context from a daily nobiletin capsule at several hundred milligrams.

The “Okinawan paradox” also warrants mention: while older Okinawan cohorts showed exceptional longevity metrics, younger Okinawans have progressively shifted toward a Westernized diet, and Okinawa no longer holds the longevity rankings it carried in the 1990s. This generational shift is consistent with a dietary-pattern interpretation of Okinawan longevity and is a caution against attributing outcomes to any single food or compound from the traditional diet.

Side effects and interactions

Nobiletin’s safety profile at supplement doses is not formally characterized in large human trials.

At dietary food levels — shikuwasa consumed as juice or condiment — the compound is likely well-tolerated given Okinawa’s population history of consumption. Concentrated supplement doses represent a higher exposure level that tolerability data from traditional food use does not automatically cover.

CYP enzyme considerations: citrus flavonoids from grapefruit and bitter orange are documented inhibitors of CYP3A4 and CYP1A2. Whether nobiletin-specific supplements produce clinically meaningful CYP inhibition at supplement doses has not been systematically characterized in pharmacokinetic studies. Anyone taking medications with narrow therapeutic windows — statins, anticoagulants, immunosuppressants, certain antiarrhythmics — should discuss citrus flavonoid supplementation with their prescribing clinician before starting.

Pregnancy and nursing: no controlled safety data exists for nobiletin supplementation during pregnancy. Standard precaution applies across all unstudied supplements in this category.

What’s actually available and how to source it

Shikuwasa as food and nobiletin as a supplement occupy distinct market categories, and the sourcing considerations differ.

Shikuwasa juice and products: Okinawan shikuwasa juice — both fresh-pressed and bottled concentrate — is available from Japanese specialty importers. Products labeling Okinawa origin and indicating green (unripe) harvest are more likely to reflect the higher nobiletin content. Shikuwasa juice from Okinawan suppliers represents the closest commercially available approximation to traditional dietary consumption, and for most purposes is a more reasonable starting point than isolated supplement extract.

Nobiletin extract supplements: a growing category of capsules standardized to nobiletin content from citrus peel (typically sweet orange, bitter orange, or shikuwasa peel combined). Products in this category should specify nobiletin percentage per serving — a product listing only total citrus peel weight provides less interpretable information. Nobiletin citrus extract supplements are available across multiple brands, with pricing in the $25–45 range for a 30-day supply.

There is no established effective human dose for nobiletin supplementation, because the dose-response data necessary to determine one does not yet exist from clinical trials. Commercial serving sizes typically range from 100 to 500 mg of nobiletin extract — these reflect market convention, not clinical trial protocols.

Who should approach this with caution

The honest framing for nobiletin in 2026: it is a biologically interesting compound with a well-characterized circadian clock mechanism in animal models and a plausible but clinically unconfirmed case for metabolic support. The Okinawan cultural context is real; the food-to-supplement extrapolation is where the evidence thins.

Individuals who should specifically consult a clinician before adding nobiletin supplements:

• Anyone taking medications metabolized by CYP3A4 or CYP1A2 — certain statins, anticoagulants, immunosuppressants, and antiarrhythmics — given the broader citrus flavonoid CYP interaction profile
• Anyone with liver or kidney disease affecting drug metabolism
• Pregnant or breastfeeding women
• Anyone already taking other citrus-based supplements or polyphenol combinations with overlapping pathways, where additive effects are not characterized

For those interested in the Okinawan dietary research: the most replicated signal from centenarian cohort data points to dietary patterns at the population level — not to any individual compound. If shikuwasa appeals as a culinary ingredient, the juice is an appropriate way to include it as part of a varied diet.

For those drawn to the circadian biology angle from the He et al. research: the findings are legitimate science. Human application remains to be established. The most robustly evidenced circadian interventions for healthy adults remain behavioral — consistent sleep timing, light exposure management, and meal timing — rather than supplement-based.

---

See also: Moringa and Okinawan nutrition: the evidence behind the superfood claim, Ashitaba and autophagy: what the chalcone research shows, Japanese resveratrol and polyphenol longevity research.